Not Yet RecruitingNCT07148206
Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- The BronxSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: October 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Montefiore Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07148206
- Official title
Show the full official title
Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
The Bronx
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Montefiore Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Dronabinol Capsules and Epidiolex 100 mg/mL Oral Solution.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
